insights_auto
Why is MBIO up 3,07%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
0,41 $
arrow_upward
+3,07%(+0,012) 1D
0,41 $
arrow_downward
-0,10% (-0,00040)bedtimeAfter hours
Closed: 12 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
0,41 $
High
0,44 $
Low
0,38 $
Mkt. cap
3,13 млн
Avg. vol.
31,29 мың
Volume
55,42 мың
52-wk high
1,69 $
52-wk low
0,38 $
EPS
-0,46 $
Beta
2,09
Shares outstanding
6,73 млн
No. of employees
4
Open
0,41 $
High
0,44 $
Low
0,38 $
Mkt. cap
3,13 млн
Avg. vol.
31,29 мың
Volume
55,42 мың
52-wk high
1,69 $
52-wk low
0,38 $
EPS
-0,46 $
Beta
2,09
Shares outstanding
6,73 млн
No. of employees
4
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 апта бұрын
MBIO Q4 2024 Earnings: Wider-Than-Expected Loss Per Share Dominates the Quarter - Profit Margin Analysis
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Массачусетс, Америка Құрама Штаттары
Sector-
Websitemustangbio.com